Tina Tai

Practice Areas

Ms. Tai has more than 27 years' experience as an IP practitioner, and worked with one of China's largest IP firms for long time as the executive member before joining KWM.

Ms. Tai is one of the most influential figures in IP law in the pharmaceutical and healthcare sectors, and has represented many influential cases including the Viagra® (Sildenafil) and Lipitor® (Atrovastatin) for Pfizer, Brillinta® (Ticagrelor) for AstraZeneca, Xarelto® (Rivaroxaban) for Bayer, Actemra® (Tocilizumab) for Roche/Chugai, Victoza® (Liraglutide) for Novo Nordisk, Entresto® (Valsartan Sacubitril) and Revolade® (Eltrombopag) for Novartis, in the patent invalidation and infringement litigations.

Ms. Tai is well experienced with the communication with the courts and government authorities including CNIPA and NMPA for patent and drug regulatory issues.